SCHEMBL20737162

SCHEMBL20737162

CCc1nc2ccccc2n1-c1ccc(-c2cc3c(c4ccccc24)-c2ccc4ccccc4c2C32c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.36
CYP1A2 P05177 1/20 0.36
FLT3 P36888 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
BMI1 P35226 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
HKDC1 Q2TB90 1/20 0.31
GSR P00390 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
MAPK10 P53779 1/20 0.30
BMX P51813 2/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737153 0.93 CYP1A2 (0.38) PDE10ACYP1A2FLT3MEN1KMT2A
SCHEMBL20737172 0.90 MAPK1 (0.42) PDE10ACYP1A2FLT3KDM4EALDH1A1
SCHEMBL27250489 0.89 PDE10A (0.37) PDE10ACYP1A2FLT3MEN1KMT2A
SCHEMBL27250553 0.89 PDE10A (0.35) PDE10ACYP1A2FLT3MEN1KMT2A
SCHEMBL20737207 0.87 PDE10A (0.37) PDE10ACYP1A2FLT3MEN1KMT2A
SCHEMBL20737174 0.87 ESR1 (0.44) FLT3MEN1KMT2AMAPTKDM4E
SCHEMBL20737226 0.86 ESR1 (0.40) FLT3MEN1KMT2AMAPTALDH1A1
SCHEMBL27250664 0.85 PDE10A (0.37) PDE10ACYP1A2FLT3MEN1KMT2A
SCHEMBL20735973 0.85 USP2 (0.38) PDE10ACYP1A2MEN1KMT2AMAPT
SCHEMBL27250575 0.84 PDE10A (0.35) PDE10ACYP1A2FLT3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885FLT3 3632/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885FLT3 3632/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885FLT3 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.